Meta-analysis of the risk of immune-related adverse events with anti-cytotoxic T-lymphocyte-associated antigen 4 and anti-programmed death 1 therapies
Komaki, Yuga, Komaki, Fukiko, Yamada, Akihiro, Micic, Dejan, Ido, Akio, Sakuraba, AtsushiLanguage:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt.633
Date:
January, 2017
File:
PDF, 3.54 MB
english, 2017